Ziv-aflibercept use in metastatic colorectal cancer. - Wikidata - awgldk - TriplyDB

Ziv-aflibercept use in metastatic colorectal cancer.

Ziv-aflibercept use in metastatic colorectal cancer.

http://www.wikidata.org/entity/Q33886059

about

Osteonecrosis of the jaw associated with ziv-aflibercept

P2860

Q37525339-0A01E840-A4C0-4AC8-8047-20E590962AA4

P2860

Ziv-aflibercept use in metastatic colorectal cancer.

http://www.wikidata.org/entity/Q33886059

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Ziv-aflibercept use in metastatic colorectal cancer.

@ast

Ziv-aflibercept use in metastatic colorectal cancer.

@en

type

label

Ziv-aflibercept use in metastatic colorectal cancer.

@ast

Ziv-aflibercept use in metastatic colorectal cancer.

@en

prefLabel

Ziv-aflibercept use in metastatic colorectal cancer.

@ast

Ziv-aflibercept use in metastatic colorectal cancer.

@en

P1433

Q33886059-43A4DEA7-B31E-4860-8F0C-F5F662EA2DC2

P1476

Q33886059-73EE039B-F695-4E8D-985B-E52F4F618F05

P2093

Q33886059-83685236-2AD6-4A4A-9BCE-AA209BC566B9

P2860

Q33886059-22A437DE-FBB0-493D-9650-0AB89C31459F

Q33886059-2901C639-B164-4102-A87F-D1008981B87C

Q33886059-29CF78C8-353A-4930-99D7-E9436E614F19

Q33886059-2FC3ACE8-346F-4352-8B01-23C2E33CCFA9

Q33886059-48D1CC13-4A27-4F4D-8B07-B006CE2526F6

Q33886059-61F51C6C-BE5F-485A-9ECC-2F8DDF4423FA

Q33886059-64DA1D3D-4A05-406B-A2F0-8E65CE3C5429

Q33886059-682087B8-B4CE-47B7-8ED7-CD0B6F0DC7D5

Q33886059-71FC971D-1BC8-474B-8CBE-FE8CD42B943F

Q33886059-8F783E33-44AD-49B5-909B-3E1181B872B3

P304

Q33886059-582D8ED5-9DED-48C8-A9AD-006E6DB719A1

P31

Q33886059-7D482563-916B-4F3A-B365-FFA90AC39141

P356

Q33886059-B195F2B7-BACF-454D-94D2-67BA2F255D59

P433

Q33886059-DE8BC877-42E9-4E04-A9AC-A78EBCBDCE52

P478

Q33886059-7FBDAF23-1470-4A33-BE15-65B66927DFCE

P577

Q33886059-3F9515B1-0878-48BD-B05B-7D12EC835669

P698

Q33886059-A1F026AB-123F-4672-99C3-DC8A5F03D14D

P921

Q33886059-24B7402D-2181-426A-9AFD-8196A2EF217F

P932

Q33886059-00EF6D1A-EA0C-4F64-AA13-EDD2E09328CA

P356

JADPRO.2013.4.5.6

P1433

Journal of the advanced practitioner in oncology

P1476

Ziv-aflibercept use in metastatic colorectal cancer.

@en

P2093

Mabel Rodriguez

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Cancer statistics, 2013

Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors.

Aflibercept in the treatment of metastatic colorectal cancer.

Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.

The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)

A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer.

A preclinical and clinical review of aflibercept for the management of cancer.

Antiangiogenic drugs for colorectal cancer: exploring new possibilities.

Targeted therapy for metastatic colorectal cancer: role of aflibercept.

P304

348-352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6004/JADPRO.2013.4.5.6

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25032013

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4093440

http://www.w3.org/2001/XMLSchema#string